OpenAlex
PricingAboutJobs
Log inGet started
Work

BCL-2 inhibition in AML: an unexpected bonus?

HTML PDF

Year: 2018
Type: review
Source: Blood
DOI: 10.1182/blood-2018-03-828269
Authors: Marina Konopleva, Anthony Letai
Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute
Language: English

Topic: Acute Myeloid Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: BCL-2 inhibition, acute myeloid leukemia, venetoclax, azacitidine, decitabine, low-dose cytarabine, combination therapy, duration of response, myeloid neoplasms
SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute
Award: Development of Novel Therapeutic Strategies in Human Leukemias
OpenAlex ID: W2884473318
FWCI: 3.197
Cites: 50
Cited by: 175
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security